Sankalp India Foundation dedicated 8th of May to commemorate both the thalassemia patients who are no longer with us but are always close in our heart and to celebrate with all those patients who are alive and fighting everyday for their right to a better quality of life.
On 21st May 2017 we also had the annual meeting of Sankalp’s advisory board. Mrs Jasmine Majethia, Dr Lawrence Faulkner, Dr Shankar, Mr S V Iyer, Mr J M Maheswariji and Mr Yogeshbhai Lakhani (special invitee) attended the meeting beside the board members of Sankalp.
As we stepped into our 15th year, we felt the need to commemorate the event with a small celebration to share the joy with the people involved with Sankalp in different capacities. The event was organized on the afternoon of 20th May 2017 at People Tree Hospital, Bangalore. In the morning the members of the executive committee of Sankalp met the members of the advisory board to chalk out the broad work strategies for the next year.
Maternal mortality continues to be a significant challenge across the developing countries and particularly relevant to India. Post-partum haemorrhage is the leading cause of maternal death. Tranexamic acid is a widely available and inexpensive drug which is routinely used for trauma patients to reduce death due to bleeding.
Recently, there was a news of 35 patients who were undergoing regular management for thalassemia in Civil Hospital Jalandhar being detected with Hepatitis C. This is not the first time such news has come out in open. This news comes as a shock. Can something be done?
